Treatment with Human Amniotic Suspension Allograft Improves Tendon Healing in a Rat Model of Collagenase-Induced Tendinopathy

• Published in: Cells (Basel, Switzerland) Vol. 8; no. 11; p. 1411
• Main Authors: de Girolamo, Laura, Morlin Ambra, Luiz Felipe, Perucca Orfei, Carlotta, McQuilling, John P, Kimmerling, Kelly A, Mowry, Katie C, Johnson, Kimberly A, Phan, Amy T, Whited, Jessica L, Gomoll, Andreas H
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 08.11.2019; MDPI
• Subjects: achilles tendon; Activities of daily living; Amniotic fluid; amniotic membrane; Animal welfare; Biomechanics; Cell density; Collagen; Collagen (type I); Collagenase; Cytokines; Degeneration; Fetuses; Growth factors; Health care; Investigations; Laboratory animals; Placenta; regenerative medicine; Statistical analysis; Stem cells; tendinopathy; Tendons; Ultrasonic imaging; United States > US; collagenase; Achilles tendon; amniotic membrane; regenerative medicine; tendinopathy
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells8111411

Treatment of tendon injuries is challenging, with neither conservative nor surgical approaches providing full recovery. Placental-derived tissues represent a promising tool for the treatment of tendon injuries. In this study, human amniotic suspension allograft (ASA) was investigated in a pre-clinical model of Achilles tendinopathy. Collagenase type I was injected in the right hind limb of Sprague Dawley rats to induce disease. Contralateral tendons were either left untreated or injected with saline as controls. Seven days following induction, tendons were injected with saline, ASA, or left untreated. Rats were sacrificed 14 and 28 days post-treatment. Histological and biomechanical analysis of tendons was completed. Fourteen days after ASA injection, improved fiber alignment and reduced cell density demonstrated improvement in degenerated tendons. Twenty-eight days post-treatment, tendons in all treatment groups showed fewer signs of degeneration, which is consistent with normal tendon healing. No statistically significant differences in histological or biomechanical analyses were observed between treatment groups at 28 days independent of the treatment they received. In this study, ASA treatment was safe, well-tolerated, and resulted in a widespread improvement of the tissue. The results of this study provide preliminary insights regarding the potential use of ASA for the treatment of Achilles tendinopathy.